Oslo, April 1, 2022 - Observe Medical ASA ("the Company" or "Observe Medical")
today announces that the Sippi® Disposable Unit has received Medical Device
Regulation Certification, ensuring continued market access for the unit in
Europe after 2024.

Rune Nystad, CEO of Observe Medical, commented: "The MDR Certification confirms
that the Sippi® Disposable Unit is compliant with the latest requirements for
medical devices in Europe. This is important as it demonstrates our commitment
not only to adhere to the latest regulatory compliance but also to ensuring our
clients that we deliver safe and high-quality products."

Having replaced the Medical Device Directive (MDD) process, the Medical Devices
Regulation (MDR) was introduced in Europe in 2021 with the aim to improve the
overall quality, safety and reliability of medical devices that are
commercialized on the European market.

"This certification marks a significant milestone for Observe Medical and
demonstrates the quality of the Sippi® Disposable Unit. Knowing the magnitude of
medical devices that would need to move from the old regulatory system, MDD, to
the new Medical Device Regulation, MDR, , Observe Medical was early to ensure
the audit of itŽs medical devices. This certification is the result of the hard
work by the dedicated team at Observe Medical, and I am proud of how far we have
come to ensure regulatory compliance our medical devices ," said Jenny
Wennerberg, QA/RA Director at Observe Medical.

The Sippi® system is Observe Medical's proprietary automated digital urine
meter. The system has wireless connectivity and can transfer data to the patient
management systems. The system also has biofilm indicator and lower the riskfor
bacterial migration that can lead to urinary infections. The Sippi® system
consists of two units, the disposable unit, the bag and measurment chamber, and
the base unit, the digital system measuring hourly diuresis.

Observe Medical is in the process of obtaining MDR Certification for the Sippi®
Base Unit, and until 2024 it is certified under MDD.  This means that the
complete Sippi® system can be sold and marketed in Europe.

For further information, please contact:


Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com

Per Arne Nygård, CFO of Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, anesthesiology/ICUs, surgery and wound care, in
combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.

Further information is available at www.observemedical.com.